Business description
Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
Management board & Supervisory board
| CEO |
| Dr. Achim von Leoprechting |
| Management board |
| Tania Micki, Andreas Wilhelm, Dr. Wael Yared, Erik Norström, Ingrid Pürgstaller, Ralf Griebel, Ulrich Kanter, Mukta Acharya |
| Supervisory board |
| Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Myra Eskes, Matthias Gillner, Monica Manotas |
Company data
| Name: |
Tecan Group AG |
| Address: |
Seestrasse 103,CH-8708 Männedorf |
| Phone: |
+41-44-922-8111 |
| Fax: |
+41-44-922-8112 |
| E-mail: |
info@tecan.com
|
| Internet: |
www.tecan.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
61.50% |
| IPO date: |
- |
Investor relations
| Name: |
Martin Brändle |
| IR phone: |
+41-44-922-8430 |
| IR Fax: |
+41-44-922-8889 |
| IR e-mail: |
investor@tecan.com
|
